Skip to main content

Shoulder Innovations, Inc.

SI
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001699350

In the last 90 days, Shoulder Innovations, Inc. insiders filed 0 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $169.1M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Shoulder Innovations, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
3 insiders, $5.09M in total
Insiders trading
3
Net value
−$5.09M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Shoulder Innovations, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Shoulder Innovations, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Ball Robert JosephCEO & Executive Chairman380,824Sep 14, 20267
Gilde Healthcare Holding B.V.10% Owner2,185,914IndirectAug 28, 20265
Ahearn Matthew FraserChief Operating Officer244,176Aug 18, 20265
Buckman PaulDirector63,750Jun 29, 20262
Tansey Casey MDirector, 10% Owner52,712Jun 29, 20261
Buchholz RichardDirector18,712Jun 29, 20262
Hykes AndrewDirector6,769Jun 29, 20261
Sidow Kevin K.Director25,056Jun 29, 20261
Points Jeffrey S.Chief Financial Officer70,785Mar 17, 20264
Blue David LawrenceSee Remarks139,372Feb 3, 20262
George JeanOther: Former 10% Owner1,885,136IndirectAug 5, 20250
Plain Henry A JROther: Former 10% Owner1,885,136IndirectAug 5, 20250
Lightstone Ventures II, L.P.Other: Former 10% Owner1,885,136IndirectAug 5, 20250
Lightstone Ventures II (A), L.P.Other: Former 10% Owner1,885,136IndirectAug 5, 20250
LSV Associates II, LLCOther: Former 10% Owner1,885,136IndirectAug 5, 20250
Carusi Michael ADirector7,666Aug 5, 20250
Pardo Geoffrey BDirector, 10% Owner7,666Aug 5, 20250

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2025 (view filing)Aug 14 daysGilde Healthcare Holding B.V.10% OwnerPPurchase+100.0K$15.00+$1.50M+4.4%2.38M after
Aug 5, 2025 (view filing)Aug 14 daysBuchholz RichardDirectorPPurchase+5.00K$15.00+$75.0K+65.2%12.7K after
Aug 5, 2025 (view filing)Aug 14 daysCarusi Michael ADirectorPPurchase+266.7K$15.00+$4.00M+16.5%1.89M after
Aug 5, 2025 (view filing)Aug 14 daysPardo Geoffrey BDirector, 10% OwnerPPurchase+100.0K$15.00+$1.50M+4.4%2.38M afterDuplicate filing
Aug 5, 2025 (view filing)Aug 14 daysPoints Jeffrey S.CHIEF FINANCIAL OFFICERPPurchase+50$15.00+$750New position50 after
Aug 5, 2025 (view filing)Aug 14 daysTansey Casey MDirector, 10% OwnerPPurchase+40.0K$15.00+$600.0K+521.8%47.7K after
Aug 5, 2025 (view filing)4:05 PM ETAug 14 daysGeorge Jean and 4 othersOther: Former 10% OwnerPPurchase+266.7K$15.00+$4.00M+16.5%1.89M afterDuplicate filing
Sep 15, 2025 (view filing)Sep 11-124 daysBall Robert JosephCEO & EXECUTIVE CHAIRMANPPurchase+8.00K$15.34+$122.7K+7.7%111.3K after2 lots
Sep 15, 2025 (view filing)Sep 123 daysPoints Jeffrey S.CHIEF FINANCIAL OFFICERPPurchase+1.60K$15.67+$25.1K+3.1%52.4K after
Dec 15, 2025 (view filing)Dec 11-124 daysBall Robert JosephCEO & Executive ChairmanPPurchase+7.20K$14.86+$107.0K+6.5%118.5K after2 lots
Dec 15, 2025 (view filing)Dec 11-124 daysPoints Jeffrey S.Chief Financial OfficerPPurchase+2.00K$14.82+$29.6K+3.8%54.4K after2 lots
Mar 17, 2026 (view filing)Mar 134 daysPoints Jeffrey S.Chief Financial OfficerPPurchase+2.00K$15.00+$30.0K+2.9%70.8K after
Mar 17, 2026 (view filing)Mar 134 daysBuchholz RichardDirectorPPurchase+1.00K$14.84+$14.8K+7.9%13.7K after
Mar 17, 2026 (view filing)Mar 134 daysBall Robert JosephCEO & Executive ChairmanPPurchase+2.20K$15.18+$33.4K+0.8%278.9K after
Jun 16, 2026 (view filing)Jun 12-154 daysAhearn Matthew FraserChief Operating OfficerSSale−20.0K$18.71−$374.3K−6.9%269.2K after3 lots10b5-1
Aug 3, 2026 (view filing)5:17 PM ETJul 30-314 daysGilde Healthcare Holding B.V.10% OwnerSSale−48.3K$23.10−$1.12M−2.0%2.33M after2 lots
Aug 5, 2026 (view filing)4:31 PM ETAug 3-42 daysGilde Healthcare Holding B.V.10% OwnerSSale−110.6K$22.76−$2.52M−4.7%2.22M after2 lots
Aug 7, 2026 (view filing)4:12 PM ETAug 5-62 daysGilde Healthcare Holding B.V.10% OwnerSSale−9.43K$22.63−$213.5K−0.4%2.21M after2 lots
Aug 18, 2026 (view filing)4:47 PM ETAug 17-181 dayAhearn Matthew FraserChief Operating OfficerSSale−22.5K$20.66−$464.8K−8.4%244.2K after3 lots10b5-1
Aug 24, 2026 (view filing)7:36 PM ETAug 20-244 daysGilde Healthcare Holding B.V.10% OwnerSSale−25.1K$22.61−$567.4K−1.1%2.19M after3 lots
Aug 28, 2026 (view filing)4:11 PM ETAug 262 daysGilde Healthcare Holding B.V.10% OwnerSSale−1.20K$22.60−$27.0K−0.1%2.19M after
Sep 14, 2026 (view filing)8:23 PM ETSep 14Same dayBall Robert JosephCEO & Executive ChairmanSSale−10.2K$18.45−$187.7K−2.6%380.8K after